Barry Manilow is recovering after catching a "cancerous spot" on his lung early. The 82-year-old singer revealed on Instagram that a lengthy bout with bronchitis led to the discovery of the cancer ...
Barry Manilow has been diagnosed with lung cancer and will be postponing his January concerts. “I’m very sorry that you have to change your plans,” the “Mandy” singer wrote in a statement posted to ...
Emily Mae Czachor is a reporter and news editor at CBSNews.com. She typically covers breaking news, extreme weather and issues involving social justice. Emily Mae previously wrote for outlets like the ...
Barry Manilow took to Instagram on Monday to reveal he’s been recently diagnosed with lung cancer. The singer/ songwriter said that he battled bronchitis for six weeks, only for it to return for ...
Singer Barry Manilow revealed on Monday that he will undergo surgery to remove a cancerous spot on his lung that was discovered after he finished a run of Christmas concerts. Manilow said that after ...
Barry Manilow has been diagnosed with lung cancer. The 82-year-old singer shared the health news on Instagram on Monday. “As many of you know, I recently went through six weeks of bronchitis followed ...
Manilow shared the news on social media. Singer-songwriter and music producer Barry Manilow announced Monday that he was diagnosed with cancer, saying it was "pure luck" that his doctors caught it ...
Barry Manilow is rescheduling his January arena concerts due to an update regarding his health. The 82-year-old beloved singer posted a statement on social media on Monday, in which he shared that he ...
Barry Manilow has been open about his long history with cigarettes. “I smoked for 30 years. I started when I was 9 years old,” the “Copacabana” singer told The Standard in 2012, revealing that he ...
AI tools like Google’s Veo 3 and Runway can now create strikingly realistic video. WSJ’s Joanna Stern and Jarrard Cole put them to the test in a film made almost entirely with AI. Watch the film and ...
A year after an FDA rejection, Johnson & Johnson has won approval for a more convenient version of its lung cancer drug Rybrevant to better challenge AstraZeneca’s Tagrisso. Rybrevant Faspro, a ...
Giving immunotherapy earlier in the day can significantly extend patients' survival, compared to giving treatment later in the day, a new study of lung cancer shows. When you purchase through links on ...